As of 2025-07-16, the Relative Valuation of Evolent Health Inc (EVH) is (40.14) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.37 USD, the upside of Evolent Health Inc based on Relative Valuation is -453.0%.
The range of the Relative Valuation is (45.63) - (40.97) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 49.2x - 55.9x | 52.2x |
| Forward P/E multiples | 28.2x - 44.1x | 34.3x |
| Fair Price | (45.63) - (40.97) | (40.14) |
| Upside | -501.3% - -460.3% | -453.0% |
| Date | P/E |
| 2025-07-15 | -12.25 |
| 2025-07-14 | -12.24 |
| 2025-07-11 | -12.05 |
| 2025-07-10 | -12.10 |
| 2025-07-09 | -12.16 |
| 2025-07-08 | -12.69 |
| 2025-07-07 | -12.54 |
| 2025-07-03 | -12.70 |
| 2025-07-02 | -12.64 |
| 2025-07-01 | -12.53 |
| 2025-06-30 | -12.13 |
| 2025-06-27 | -12.02 |
| 2025-06-26 | -11.58 |
| 2025-06-25 | -11.54 |
| 2025-06-24 | -11.44 |
| 2025-06-23 | -11.31 |
| 2025-06-20 | -9.97 |
| 2025-06-18 | -9.32 |
| 2025-06-17 | -9.15 |
| 2025-06-16 | -8.81 |
| 2025-06-13 | -8.91 |
| 2025-06-12 | -9.10 |
| 2025-06-11 | -9.31 |
| 2025-06-10 | -9.66 |
| 2025-06-09 | -9.14 |
| 2025-06-06 | -8.98 |
| 2025-06-05 | -8.82 |
| 2025-06-04 | -8.74 |
| 2025-06-03 | -9.21 |
| 2025-06-02 | -8.16 |
| 2025-05-30 | -8.03 |
| 2025-05-29 | -7.94 |
| 2025-05-28 | -8.23 |
| 2025-05-27 | -8.30 |
| 2025-05-23 | -7.77 |
| 2025-05-22 | -7.93 |
| 2025-05-21 | -8.62 |
| 2025-05-20 | -9.45 |
| 2025-05-19 | -9.29 |
| 2025-05-16 | -9.51 |
| 2025-05-15 | -9.50 |
| 2025-05-14 | -9.63 |
| 2025-05-13 | -9.99 |
| 2025-05-12 | -10.03 |
| 2025-05-09 | -9.75 |
| 2025-05-08 | -11.61 |
| 2025-05-07 | -11.26 |
| 2025-05-06 | -11.15 |
| 2025-05-05 | -11.38 |
| 2025-05-02 | -11.52 |